Allied Market Research


Learning Disabilities Treatment Market

Learning Disabilities Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Therapy, by Indication and by End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Learning disability treatment market is expected to witness growth in upcoming years. There is no specific treatment available for the cure of the disability completely. There is an increase in demand for the medicines available for the patients, which are prescribed by the psychiatrists.


Learning disability is a neurological disorder that can affect the response power and perception of information in humans. There is no cure available for the disorder but early diagnosis can help in lowering the intensity of the disease. Learning disability treatment assists in developing the strength for learning. Learning disabilities include various disorders such as dyslexia, dyscalculia, dysgraphia, dyspraxia, auditory and visual processing disorders and attention deficit hyperactivity disorder (ADHD). Some of the medicines that are available for the treatment of the patients suffering from ADHD and cognitive disability. Medicines for the learning disability treatment are segmented into stimulant and non -stimulant.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on the learning disabilities treatment market.

Top Impacting factors:

  • Learning disability treatment is expected to grow in upcoming years. There is no specific treatment available for a complete cure of the disorder.
  • Demand for prescribed medicines by the psychiatrists for the patients is expected to drive the growth for the market.
  • Special schools are providing opportunities for learning and are gaining popularity. Parents are preferring the option of special schools for education in affected children. Advancements are made in the technology has influenced in the assistive teaching, software and applications for behavioral and occupational therapy.
  • However, lack of special schools in underdeveloped countries can hamper the growth of market up to some extent over the forecast period. 

New Product Launch / News:

In May 2020,NHS England revealed that 1,029 people with a learning disability died in England between March 16 and May 10, with 45.4% (467) reported to The Learning Disabilities Mortality Review (LeDeR) linked to coronavirus. Responding to the data, learning disabilities charity Mencap said this is a higher percentage than the proportion of COVID-19-related deaths in care homes, at 31.1%Mencap warned that people with a learning disability are “being forgotten in this crisis” and called for urgent action to address “address any potentially discriminatory practice now”.

In April 2020, University of Cambridge researchers used artificial intelligence (AI) machine learning to demonstrate how the brain’s neural hubs, rather than brain regions, are a strong predictor of learning-related cognitive problems in children.

Key benefits of the report:

  • This study presents the analytical depiction of the learning disabilities treatment market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Learning disability treatment market share.
  • The current market is quantitatively analyzed to highlight the Learning disability treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed learning disabilities treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Learning Disabilities Treatment Market Report:

  • What are the leading market players active in learning disabilities treatment market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

Learning Disabilities Treatment Market Report Highlights

Aspects Details
By Therapy
  • Stimulant Medication
    • Methylphenidate (Ritalin, Concerta)
    • Dexmethylphenidate (Focalin)
    • Amphetamine/Dextroamphetamine (Adderall, Dexedrine, Dextrostat)
    • Lisdexamfetamine (Vyvanse)
  • Non-Stimulant Medication
  • Occupational Therapy
  • Orton Gillingham Interventional Therapy
  • Others (Antidepressants – bupropion (Wellbutrin) Tricyclics – imipramine (Tofranil), nortriptyline (Pamelor, Aventyl), desipramine (Norpramin) Alpha-2 agonists – clondine (Catapres), guanfacine (Tenex)).
By Indication
  • Dyslexia
  • Dyspraxia
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Others
By End Users
  • Hospitals
  • Clinic
  • Others
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (Germany, France, UK, Spain, Italy, rest of Europe)
  • Asia-Pacific  (China, India, Japan, Australia, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, rest of LAMEA)
Key Market Players

Therapro, Inc., IMSE., Novartis AG and Shire Plc., Eli Lilly and Company, Pfizer, Inc, Texthelp Ltd., CogniFit, Tumble N’ Dots, Inc., Forest Laboratories, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Learning Disabilities Treatment Market

Global Opportunity Analysis and Industry Forecast, 2023-2032